|

Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions

RECRUITINGPhase 4Sponsored by Weill Medical College of Cornell University
Actively Recruiting
PhasePhase 4
SponsorWeill Medical College of Cornell University
Started2017-02-13
Est. completion2025-12-31
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03218137

Summary

Unblinded, controlled, non-randomized, mechanistic study to determine whether physiological mechanisms underlying PVC are sensitive to adenosine. One hundred subjects undergoing clinically-indicated, standard-of-care cardiac electrophysiology study (EPS) procedure for PVCs will receive adenosine and/or verapamil to learn if their arrhythmias are inducible similarly to sustained ventricular tachycardia.

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosis of premature ventricular contractions (PVCs)
* Scheduled to undergo an electrophysiology study with the intention of performing cardiac ablation for the treatment of PVCs
* Male or female between the ages of 18 and 70 years
* Capable of giving informed consent

Exclusion Criteria:

* Any structural heart disease
* Coronary artery disease (≥ 70% stenosis)
* Current treatment with anti-arrhythmic drugs
* Pregnant
* Asthma (if administering adenosine)

Conditions2

Heart DiseasePremature Ventricular Contraction (PVC)

Locations1 site

Weill Cornell Medicine
New York, New York, 10065
Dolores T Reynolds, BSN212 746 4617dtr2001@med.cornell.edu

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.